The estimated Net Worth of Heather D Turner is at least $715 Thousand dollars as of 9 February 2018. Heather Turner owns over 12,214 units of Sangamo Therapeutics Inc stock worth over $58,375 and over the last 9 years Heather sold SGMO stock worth over $656,274.
Heather has made over 2 trades of the Sangamo Therapeutics Inc stock since 2017, according to the Form 4 filled with the SEC. Most recently Heather sold 12,214 units of SGMO stock worth $464,254 on 9 February 2018.
The largest trade Heather's ever made was selling 12,215 units of Sangamo Therapeutics Inc stock on 9 February 2017 worth over $192,020. On average, Heather trades about 2,036 units every 30 days since 2015. As of 9 February 2018 Heather still owns at least 69,494 units of Sangamo Therapeutics Inc stock.
You can see the complete history of Heather Turner stock trades at the bottom of the page.
Heather's mailing address filed with the SEC is 611 Gateway Blvd Suite 900, South San Francisco, CA 94080, USA.
Over the last 24 years, insiders at Sangamo Therapeutics Inc have traded over $87,969,621 worth of Sangamo Therapeutics Inc stock and bought 3,434,008 units worth $48,483,268 . The most active insiders traders include Capital Management, L.P.Ra ..., Le Roy C Kopp, and Inc.Biogen Ma Inc. Biogen. On average, Sangamo Therapeutics Inc executives and independent directors trade stock every 21 days with the average trade being worth of $40,671. The most recent stock trade was executed by Inc.Biogen Ma Inc. Biogen on 26 September 2023, trading 6,000,000 units of SGMO stock currently worth $3,000,000.
for sangamo therapeutics, science is a means to develop new medicines with the potential to transform the lives of patients living with serious genetic diseases. our scientists are leaders in the discovery, research and development of technologies enabling gene-based therapeutic development. currently we are conducting clinical trials, including the first ever in vivo human genome editing studies. to learn more about sangamo, visit the our website at www.sangamo.com.
Sangamo Therapeutics Inc executives and other stock owners filed with the SEC include: